Health
South Korean hospitals extend working hours to cope with doctors’ protest
South Korea’s public hospitals will extend their working hours while expanding the use of telemedicine to ease growing pressure on health services following a mass
GSK’s injectable HIV drug is more promising
British drugmaker GSK said Wednesday that its long-acting injectable HIV therapy showed promising results in maintaining a suppressed viral load compared with daily oral treatment,
Indian drug companies develop versions of Wegovy
Indian drug companies have started developing their own versions of Novo Nordisk’s Wegovy. With some analysts predicting that the weight loss market will reach $100
United Therapeutics begins litigation with FDA over rival Liquidia’s drug application
United Therapeutics said Wednesday it has filed a lawsuit with the U.S. Food and Drug Administration, alleging that proper procedures were not followed to allow
More than half the world faces a high risk of contracting measles
More than half of the world’s countries will be at high or very high risk of measles outbreaks by the end of the year unless
Johnson & Johnson’s blood cancer drug has received US FDA approval
The US Food and Drug Administration has approved Johnson & Johnson’s biweekly dose of Tecvayli blood cancer therapy. The approval allows the therapy to be
South Korean trainee doctors strike against quotas in medical schools
More than 1,600 trainee doctors at South Korea’s biggest hospitals went on strike Tuesday to protest a government plan to admit more students to medical
US study identifies 275 million brand new genetic variants
The study, which analysed the genetic code of a quarter of a million volunteers in the US, identified more than 275 million brand-new variants that
EU medicines regulator to review Lilly’s Mounjaro multi-dose pen
The European Union’s health regulator this week will review the use of Eli Lilly’s approved diabetes and obesity drug Munjaro in pre-filling a multi-dose injection
Pfizer’s drug for inflammatory bowel disease has received EU approval
A drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission. The approval of Velsipity followed